Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Lavipharm

Lavipharm
1911 FOUNDED
PUBLIC STATUS
LAVI STOCK SYMBOL
$0.31 SHARE PRICE (As of Tuesday Closing)
Description

Lavipharm SA develops, manufactures, markets and distributes pharmaceutical, cosmetic and consumer health products in Greece and internationally. The company's product portfolio includes innovative, safe and effective therapeutic solutions that meet consumer' needs for health and wellbeing. Its main product categories are Cardiology, Oncology, Urology, Neurology, Psychiatry, General Medicine, Self- Treatment and Dermocosmetic care.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
ATH
Primary Office
  • Agias Marinas Street
  • PO Box 59
  • Paiania, 190 02
  • Greece

+30 21 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Lavipharm’s full profile, request a free trial.

Lavipharm Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.13 - $0.43 $16.1M $0.31 25.8K
Public Fundamental Data provided by Morningstar, Inc. disclaimer